C. Spiropoulou

Timothy D. Flietstra, Jay B. Varkey, A. Mehta, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Laboratory Response to Ebola - West Africa and United States.

J. Klena, C. Spiropoulou, B. Bird, 2016, MMWR supplements.

Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Timothy D. Flietstra, A. McElroy, P. Rollin, 2014, The Journal of infectious diseases.

Andes Virus Disrupts the Endothelial Cell Barrier by Induction of Vascular Endothelial Growth Factor and Downregulation of VE-Cadherin

P. Rollin, C. Spiropoulou, P. Shrivastava-Ranjan, 2010, Journal of Virology.

Hantavirus Infection Induces the Expression of RANTES and IP-10 without Causing Increased Permeability in Human Lung Microvascular Endothelial Cells

P. Rollin, C. Peters, C. Spiropoulou, 2001, Journal of Virology.

Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model

J. Klena, S. Nichol, C. Spiropoulou, 2018, The Journal of infectious diseases.

Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome.

H. Feldmann, T. Ksiazek, P. Rollin, 1993, Virus research.

Host mTORC1 Signaling Regulates Andes Virus Replication

S. Nichol, C. Spiropoulou, M. Flint, 2012, Journal of Virology.

Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture

J. Montgomery, S. Nichol, C. Spiropoulou, 2020, Frontiers in Cellular and Infection Microbiology.

Hantavirus maturation.

C. Spiropoulou, 2001, Current topics in microbiology and immunology.

Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome.

B. Hjelle, C. Peters, S. Nichol, 1994, The Journal of infectious diseases.

Sin Nombre virus glycoprotein trafficking.

R. Compans, C. Goldsmith, C. Peters, 2003, Virology.

Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome.

C. Peters, S. Nichol, C. Spiropoulou, 1996, The Journal of infectious diseases.

Retrospective serological and genetic study of the distribution of hantaviruses in Greece

T. Ksiazek, S. Nichol, C. Spiropoulou, 1998, Journal of medical virology.

Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform

J. Montgomery, S. Nichol, C. Spiropoulou, 2021, Viruses.

Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus Disease

J. Montgomery, S. Nichol, C. Spiropoulou, 2022, mBio.

Twenty Years of Nipah Virus Research: Where Do We Go From Here?

E. Gurley, C. Spiropoulou, E. de Wit, 2020, The Journal of infectious diseases.

Adaptive immune responses in humans during Nipah virus acute and convalescent phases of infection.

K. Laserson, A. McElroy, J. Klena, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Conserved Basic Patch and Central Kink in the Nipah Virus Phosphoprotein Multimerization Domain Are Essential for Polymerase Function.

E. Saphire, C. Spiropoulou, A. Hotard, 2019, Structure.

Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis.

S. Nichol, C. Spiropoulou, M. Flint, 2019, The Lancet. Infectious diseases.

Crimean-Congo hemorrhagic fever and expansion from endemic regions.

C. Spiropoulou, É. Bergeron, Jessica R. Spengler, 2019, Current opinion in virology.

Viral RNA and infectious virus in mucosal specimens from guinea pigs modelling early phases of lethal and non-lethal Lassa fever

J. Montgomery, C. Spiropoulou, Jessica R. Spengler, 2022, Emerging microbes & infections.

Ebola Virus Persistence in Semen of Male Survivors.

Jay B. Varkey, A. Schuh, A. Mehta, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus.

G. Olinger, L. Hensley, S. Nichol, 2016, Antiviral research.

Activation and cell death in human dendritic cells infected with Nipah virus.

C. Spiropoulou, Manisha Gupta, Michael K. Lo, 2013, Virology.

Complete Genome Sequences of a Hantavirus Isolate from New York

T. Ksiazek, S. Nichol, C. Spiropoulou, 2018, Genome Announcements.

Rapid detection of vesicular stomatitis virus New Jersey serotype in clinical samples by using polymerase chain reaction

S. Nichol, C. Spiropoulou, L. Rodriguez, 1993, Journal of clinical microbiology.

Chapare Hemorrhagic Fever and Virus Detection in Rodents in Bolivia in 2019.

C. Goldsmith, J. Montgomery, J. Klena, 2022, The New England journal of medicine.

Nipah Virus Outbreaks: Still Small but Extremely Lethal.

C. Spiropoulou, 2018, The Journal of infectious diseases.

Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.

J. Rose, S. Nichol, C. Spiropoulou, 2014, Antiviral research.

Personal Protective Equipment for Filovirus Epidemics: A Call for Better Evidence

G. Kobinger, H. Feldmann, C. Spiropoulou, 2015, The Journal of infectious diseases.

25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation

S. Nichol, C. Spiropoulou, M. Flint, 2016, mBio.

Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.

D. Weissman, J. Montgomery, S. Nichol, 2019, The Journal of infectious diseases.

4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency.

B. He, S. Nichol, C. Spiropoulou, 2017, Antiviral research.

Exploring inactivation of SARS-CoV-2, MERS-CoV, Ebola, Lassa, and Nipah viruses on N95 and KN95 respirator material using photoactivated methylene blue to enable reuse

B. Harcourt, J. Montgomery, C. Spiropoulou, 2022, American Journal of Infection Control.

Probing the Effects of Pyrimidine Functional Group Switches on Acyclic Fleximer Analogues for Antiviral Activity

J. Plavec, C. Spiropoulou, M. Flint, 2019, Molecules.

Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.

S. Nichol, C. Spiropoulou, M. Flint, 2016, Antiviral research.

A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 Protease

S. Kunz, A. Pasquato, C. Spiropoulou, 2015, Journal of Virology.

Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)

R. Schooley, J. Montgomery, C. Spiropoulou, 2021, bioRxiv.

Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection

S. Nichol, C. Spiropoulou, S. Pegan, 2019, mBio.

Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds

S. Nichol, C. Spiropoulou, C. Albariño, 2018, PLoS neglected tropical diseases.

Site 1 Protease Is Required for Proteolytic Processing of the Glycoproteins of the South American Hemorrhagic Fever Viruses Junin, Machupo, and Guanarito

S. Kunz, Jillian M. Rojek, Ngoc-Phuong-Thao Nguyen, 2008, Journal of Virology.

Crimean-Congo Hemorrhagic Fever Virus Suppresses Innate Immune Responses via a Ubiquitin and ISG15 Specific Protease.

S. Nichol, C. Spiropoulou, S. Pegan, 2017, Cell reports.

Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)

R. Schooley, J. Montgomery, C. Spiropoulou, 2021, Microbiology spectrum.

Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.

S. Nichol, C. Spiropoulou, É. Bergeron, 2019, Antiviral research.

Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice

S. Nichol, C. Spiropoulou, S. Pegan, 2019, Emerging microbes & infections.

Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge

H. Feldmann, Jacqueline Cronin, R. Jordan, 2019, Science Translational Medicine.

Viral replicon particles protect IFNAR-/- mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccination.

J. Montgomery, S. Nichol, C. Spiropoulou, 2021, Antiviral research.

The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.

C. Spiropoulou, Jessica R. Spengler, M. Zivcec, 2020, Antiviral research.

Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection

J. Keck, A. McElroy, C. Goldsmith, 2017, The Journal of infectious diseases.

Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice

J. Keck, A. McElroy, S. Nichol, 2018, PloS one.

A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus.

C. Schmaljohn, C. Spiropoulou, A. Estrada-Peña, 2016, Antiviral research.

Rift Valley Fever Virus Clearance and Protection from Neurologic Disease Are Dependent on CD4+ T Cell and Virus-Specific Antibody Responses

A. McElroy, S. Nichol, C. Spiropoulou, 2013, Journal of Virology.

Human immune system mouse models of Ebola virus infection.

H. Feldmann, C. Spiropoulou, Joseph B. Prescott, 2017, Current opinion in virology.

Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis

J. Sidney, A. Sette, A. McElroy, 2021, Journal of virology.

CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis

A. McElroy, S. Nichol, C. Spiropoulou, 2018, Journal of Virology.

Rift Valley Fever Virus Encephalitis Is Associated with an Ineffective Systemic Immune Response and Activated T Cell Infiltration into the CNS in an Immunocompetent Mouse Model

A. McElroy, S. Zaki, S. Nichol, 2014, PLoS neglected tropical diseases.

Rift Valley Fever Virus Vaccine Lacking the NSs and NSm Genes Is Safe, Nonteratogenic, and Confers Protection from Viremia, Pyrexia, and Abortion following Challenge in Adult and Pregnant Sheep

A. McElroy, S. Nichol, C. Spiropoulou, 2011, Journal of Virology.

Lassa virus antigen distribution and inflammation in the ear of infected strain 13/N guinea pigs.

W. Shieh, S. Zaki, S. Nichol, 2020, Antiviral research.

Protection from lethal Lassa disease can be achieved both before and after virus exposure by administration of single-cycle replicating Lassa virus replicon particles.

C. Goldsmith, S. Nichol, C. Spiropoulou, 2019, The Journal of infectious diseases.

Reverse Genetics Recovery of Lujo Virus and Role of Virus RNA Secondary Structures in Efficient Virus Growth

S. Nichol, C. Spiropoulou, B. Bird, 2012, Journal of Virology.

Small Interfering RNA Inhibition of Andes Virus Replication

C. Spiropoulou, Cheng-Feng Chiang, C. Albariño, 2014, PloS one.

In Situ Imaging of Fluorescent Nipah Virus Respiratory and Neurological Tissue Tropism in the Syrian Hamster Model.

J. Montgomery, S. Nichol, C. Spiropoulou, 2019, The Journal of infectious diseases.

A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses

Jay B. Varkey, J. Sidney, A. Sette, 2017, The Journal of infectious diseases.

Biomarkers for understanding Ebola virus disease.

A. McElroy, C. Spiropoulou, 2014, Biomarkers in medicine.

"In order to identify currently licensed drugs that might be beneficial, we need to know more about the pathophysiology of the disease. Biomarker analyses could prove to be useful for this purpose."

A. McElroy, C. Spiropoulou, 2014 .

Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro.

P. Rollin, C. Spiropoulou, Manisha Gupta, 2007, Virology.

Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus.

A. MacNeil, P. Rollin, C. Spiropoulou, 2012, Virology.

Kyasanur Forest Disease Virus Infection in Mice Is Associated with Higher Morbidity and Mortality than Infection with the Closely Related Alkhurma Hemorrhagic Fever Virus

S. Nichol, C. Spiropoulou, B. Bird, 2014, PloS one.

Antibodies Against Henipa-Like Viruses in Brazilian Bats.

P. Rota, A. Tamin, C. Spiropoulou, 2017, Vector borne and zoonotic diseases.

Genome Sequences of Crimean-Congo Hemorrhagic Fever Virus Strains Isolated in South Africa, Namibia, and Turkey

T. Ksiazek, P. Rollin, S. Nichol, 2017, Genome Announcements.

Interferon induction by viruses. XXII. Vesicular stomatitis virus-Indiana: M-protein and leader RNA do not regulate interferon induction in chicken embryo cells.

S. Nichol, C. Spiropoulou, P. I. Marcus, 1993, Journal of Interferon Research.

Suboptimal Handling of Piccolo Samples or Reagent Discs for Consideration in Ebola Response

S. Nichol, C. Spiropoulou, Jessica R. Spengler, 2019, Emerging infectious diseases.

Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster Model.

J. Montgomery, S. Nichol, C. Spiropoulou, 2019, The Journal of infectious diseases.

Flex-nucleoside analogues – Novel therapeutics against filoviruses

S. Bavari, C. Spiropoulou, M. Flint, 2017, Bioorganic & Medicinal Chemistry Letters.

Rapid Determination of Ebolavirus Infectivity in Clinical Samples Using a Novel Reporter Cell Line

S. Nichol, C. Spiropoulou, C. Albariño, 2017, The Journal of infectious diseases.

Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations

L. Nyakarahuka, A. McElroy, S. Nichol, 2018, PLoS neglected tropical diseases.

Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection

Timothy D. Flietstra, A. McElroy, S. Nichol, 2018, The Journal of infectious diseases.

Sustained Replication of Synthetic Canine Distemper Virus Defective Genomes In Vitro and In Vivo

W. P. Duprex, S. Nichol, Reed S Shabman, 2021, bioRxiv.

Whole Blood-Based Multiplex Immunoassays for the Evaluation of Human Biomarker Responses to Emerging Viruses in Resource-Limited Regions.

A. McElroy, S. Nichol, C. Spiropoulou, 2017, Viral immunology.

Reply to Fedson.

A. McElroy, C. Spiropoulou, 2015, The Journal of infectious diseases.

Von Willebrand factor is elevated in individuals infected with Sudan virus and is associated with adverse clinical outcomes.

Timothy D. Flietstra, A. McElroy, P. Rollin, 2015, Viral immunology.

Tracing Dobrava hantavirus infection.

C. Spiropoulou, A. Papa, A. Antoniadis, 2000, The Journal of infectious diseases.

Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease.

C. Goldsmith, S. Zaki, S. Nichol, 2016, The Journal of infectious diseases.

Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines

Manish M Patel, M. Exline, W. Self, 2021, Nature Communications.

Old World and Clade C New World Arenaviruses Mimic the Molecular Mechanism of Receptor Recognition Used by (cid:2) -Dystroglycan’s Host-Derived Ligands (cid:1)

K. Campbell, S. Kunz, Jillian M. Rojek, 2007 .

Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus.

P. Rollin, C. Goldsmith, C. Spiropoulou, 2010, Virology.

Using Humanized Mice to Evaluate the Pathogenesis of Variola Virus and Ebolavirus

C. Goldsmith, S. Zaki, C. Spiropoulou, 2018, Microscopy and Microanalysis.

Vascular events in viral hemorrhagic fevers: a comparative study of dengue and hantaviruses

C. Spiropoulou, A. Srikiatkhachorn, 2014, Cell and Tissue Research.

Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses

Jens H. Kuhn, Wenhui Li, N. Andrews, 2007, Nature.

High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay

Timothy D. Flietstra, A. Schuh, J. Montgomery, 2020, Scientific Reports.

Inhibition of Nipah Virus by Defective Interfering Particles.

W. P. Duprex, S. Nichol, C. Spiropoulou, 2020, The Journal of infectious diseases.

Inhibitors of the Tick-Borne, Hemorrhagic Fever-Associated Flaviviruses

S. Nichol, C. Spiropoulou, M. Flint, 2014, Antimicrobial Agents and Chemotherapy.

The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model

J. Klena, S. Nichol, C. Spiropoulou, 2018, Front. Cell. Infect. Microbiol..

Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus

Joshua C. Johnson, P. Shinn, R. Guha, 2016, PloS one.

Identification of 2′‐deoxy‐2′‐fluorocytidine as a potent inhibitor of Crimean‐Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus

S. Nichol, C. Spiropoulou, M. Flint, 2017, Antiviral research.

Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus

C. Spiropoulou, É. Bergeron, Jessica R. Spengler, 2016, Viruses.

Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination

Paul G. Thomas, Helder I. Nakaya, Katherine J.L. Jackson, 2022 .

A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus

S. Nichol, C. Spiropoulou, M. Flint, 2019, Nature Communications.

Design, synthesis and biological evaluation of 2-substituted-6-[(4-substituted-1-piperidyl)methyl]-1H-benzimidazoles as inhibitors of ebola virus infection.

A. Bojarski, C. Spiropoulou, D. Warszycki, 2021, European journal of medicinal chemistry.

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing

A. McElroy, S. Nichol, C. Spiropoulou, 2018, mBio.

Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses.

S. Nichol, C. Spiropoulou, M. Flint, 2015, Antiviral research.

Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening.

S. Nichol, C. Spiropoulou, Michael K. Lo, 2014, Antiviral research.

Lassa Virus Targeting of Anterior Uvea and Endothelium of Cornea and Conjunctiva in Eye of Guinea Pig Model

S. Zaki, S. Nichol, C. Spiropoulou, 2019, Emerging infectious diseases.

Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases

R. Jordan, J. Montgomery, S. Nichol, 2020, Proceedings of the National Academy of Sciences.

Inference of Nipah virus evolution, 1999-2015.

J. Montgomery, J. Ladner, E. Gurley, 2020, Virus evolution.

Identification of a new North American hantavirus that causes acute pulmonary insufficiency.

A. Sanchez, H. Feldmann, Ali S Khan, 1995, The American journal of tropical medicine and hygiene.

Isolation of the causative agent of hantavirus pulmonary syndrome.

J. Childs, G. Maupin, K. Gage, 1994, The American journal of tropical medicine and hygiene.

Distinct and Overlapping Roles of Nipah Virus P Gene Products in Modulating the Human Endothelial Cell Antiviral Response

W. Bellini, P. Rota, M. Peeples, 2012, PloS one.

Immunologic timeline of Ebola virus disease and recovery in humans.

G. Nolan, A. Mehta, Rama S. Akondy, 2020, JCI insight.

Host-Species Transferrin Receptor 1 Orthologs Are Cellular Receptors for Nonpathogenic New World Clade B Arenaviruses

S. Radoshitzky, M. Farzan, H. Choe, 2009, PLoS pathogens.

Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses

J. Kuhn, S. Radoshitzky, S. Ross, 2008, Proceedings of the National Academy of Sciences.

Clinical care of two patients with Ebola virus disease in the United States.

Jay B. Varkey, A. Mehta, G. Lyon, 2014, The New England journal of medicine.

Mouse models of Ebola virus tolerance and lethality: Characterization of CD-1 mice infected with wild-type, guinea pig-adapted, or mouse-adapted virus.

Steven B. Bradfute, J. Montgomery, C. Spiropoulou, 2022, Antiviral research.

Developing Therapeutics for Ebola Virus Disease: A Multifaceted Approach

C. Spiropoulou, Jessica R. Spengler, Michael K. Lo, 2019, Neglected Tropical Diseases.

Human Ebola virus infection results in substantial immune activation

Jay B. Varkey, J. Sidney, A. Sette, 2015, Proceedings of the National Academy of Sciences.

Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver

H. Feldmann, J. Keck, S. Nichol, 2017, The Journal of infectious diseases.

Endocytic Pathways Used by Andes Virus to Enter Primary Human Lung Endothelial Cells

C. Spiropoulou, M. Flint, Cheng-Feng Chiang, 2016, PloS one.

Old World and Clade C New World Arenaviruses Mimic the Molecular Mechanism of Receptor Recognition Used by α-Dystroglycan's Host-Derived Ligands

K. Campbell, S. Kunz, Jillian M. Rojek, 2007, Journal of Virology.

Susceptibility of paramyxoviruses and filoviruses to inhibition by 2′-monofluoro- and 2′-difluoro-4′-azidocytidine analogs

Paul C Jordan, S. Nichol, C. Spiropoulou, 2018, Antiviral Research.

A small highly basic protein is encoded in overlapping frame within the P gene of vesicular stomatitis virus

S. Nichol, C. Spiropoulou, S T Nichol, 1993, Journal of virology.

Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses

A. McElroy, S. Nichol, C. Spiropoulou, 2020, npj Vaccines.

Characterization of the Interaction of Lassa Fever Virus with Its Cellular Receptor α-Dystroglycan

S. Kunz, Jillian M. Rojek, Mar Perez, 2005, Journal of Virology.

Posttranslational Modification of α-Dystroglycan, the Cellular Receptor for Arenaviruses, by the Glycosyltransferase LARGE Is Critical for Virus Binding

K. Campbell, S. Kunz, Jillian M. Rojek, 2005, Journal of Virology.

New World Arenavirus Clade C, but Not Clade A and B Viruses, Utilizes α-Dystroglycan as Its Major Receptor

K. Campbell, P. Rollin, S. Kunz, 2002, Journal of Virology.

Severe Hemorrhagic Fever in Strain 13/N Guinea Pigs Infected with Lujo Virus

S. Nichol, C. Spiropoulou, B. Bird, 2012, PLoS neglected tropical diseases.

The Crimean-Congo Hemorrhagic Fever Virus NSm Protein Is Dispensable for Growth In Vitro and Disease in Ifnar-/- Mice

S. Zaki, S. Nichol, C. Spiropoulou, 2020, Microorganisms.

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.

Elizabeth L. Beam, Sean G. Kaufman, Jennifer A. Schuck, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An introduction to the Marburg virus vaccine consortium, MARVAC

J. Dye, I. Longini, S. Günther, 2022, PLoS pathogens.

Identification of broadly neutralizing monoclonal antibodies against Crimean‐Congo hemorrhagic fever virus

S. Nichol, C. Spiropoulou, C. Albariño, 2017, Antiviral research.

Ebola Virus Diagnostics: The US Centers for Disease Control and Prevention Laboratory in Sierra Leone, August 2014 to March 2015.

A. Brault, A. Schuh, C. Paddock, 2015, The Journal of infectious diseases.

Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment.

H. Feldmann, J. Keck, S. Nichol, 2016, The Journal of infectious diseases.

Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice

G. Kobinger, A. McElroy, S. Zaki, 2019, PLoS pathogens.

Andes and Prospect Hill Hantaviruses Differ in Early Induction of Interferon although Both Can Downregulate Interferon Signaling

T. Ksiazek, P. Rollin, C. Spiropoulou, 2007, Journal of Virology.

Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness.

F. Ennis, C. Peters, S. Nichol, 1997, Virology.

Posttranslational Modification of α-Dystroglycan, the Cellular Receptor for Arenaviruses, by the Glycosyltransferase LARGE Is Critical for Virus Binding

K. Campbell, S. Kunz, Jillian M. Rojek, 2005, Journal of Virology.

A single mutation in Crimean-Congo hemorrhagic fever virus discovered in ticks impairs infectivity in human cells

C. Drosten, S. Nichol, C. Spiropoulou, 2020, eLife.

Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus

Ian A. Durie, M. Sajadi, C. Spiropoulou, 2022, Nature Communications.

Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin

S. Nichol, C. Spiropoulou, C. Albariño, 2015, PLoS pathogens.

Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical disease.

A. Schuh, J. Montgomery, C. Spiropoulou, 2022, Antiviral Research.

Novel Paramyxovirus Associated with Severe Acute Febrile Disease, South Sudan and Uganda, 2012

D. Reeder, P. Rota, P. Rollin, 2014, Emerging infectious diseases.

Development of a novel minigenome and recombinant VSV expressing Seoul hantavirus glycoprotein-based assays to identify anti-hantavirus therapeutics.

J. Montgomery, C. Spiropoulou, M. Flint, 2023, Antiviral research.

Potent in vitro activity of β-D-4'-chloromethyl-2'-deoxy-2'-fluorocytidine against Nipah virus.

R. Schinazi, S. Nichol, C. Spiropoulou, 2020, Antiviral research.

Fatal illness associated with a new hantavirus in Louisiana

Ali S Khan, S. Zaki, M. Kohn, 1995, Journal of medical virology.

Hantavirus pulmonary syndrome

A. MacNeil, S. Simpson, S. Nichol, 1996, The Lancet.

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

William A. Lee, Jeffrey R. Kugelman, G. Palacios, 2016, Nature.

Late remdesivir treatment initiation partially protects African green monkeys from lethal Nipah virus infection.

T. Cihlar, C. Spiropoulou, E. de Wit, 2023, Antiviral research.

Immunogenicity of poxvirus-based vaccines against Nipah virus

J. Montgomery, C. Spiropoulou, J. Osorio, 2023, Scientific reports.

Development of a neutralization assay using a vesicular stomatitis virus expressing Nipah virus glycoprotein and a fluorescent protein.

J. Montgomery, J. Klena, M. Rahman, 2023, Virology.

Immunobiology of Crimean-Congo hemorrhagic fever.

S. Nichol, C. Spiropoulou, B. Bird, 2022, Antiviral research.

Ebola Virus Persistence in Semen of Male Survivors.

Jay B. Varkey, A. Schuh, A. Mehta, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of Vandetanib on Andes virus survival in the hamster model of Hantavirus pulmonary syndrome.

C. Spiropoulou, B. Bird, K. Dodd, 2016, Antiviral research.

Hantavirus pulmonary syndrome.

A. MacNeil, S. Nichol, C. Spiropoulou, 2011, Virus research.

Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination

C. Goldsmith, J. Montgomery, S. Nichol, 2023, Science advances.

RIG-I activation inhibits ebolavirus replication.

P. Ranjan, T. Fujita, T. Ksiazek, 2009, Virology.

Optimal reference genes for RNA tissue analysis in small animal models of hemorrhagic fever viruses

C. Spiropoulou, S. R. Welch, J. Brignone, 2023, Scientific reports.

Development of reverse genetic tools to study Chapare and Machupo viruses.

C. Spiropoulou, M. Flint, C. Albariño, 2023, Virology.

Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation.

C. Spiropoulou, J. Towner, J. Spengler, 2023, The Journal of infectious diseases.

Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination

C. Spiropoulou, C. Albariño, É. Bergeron, 2023, Emerging microbes & infections.

Biomarkers for understanding Ebola virus disease.

A. McElroy, C. Spiropoulou, 2014, Biomarkers in medicine.

Streamlined detection of Nipah virus antibodies using a split NanoLuc biosensor

C. Spiropoulou, Cheng-Feng Chiang, S. Satter, 2024, Emerging microbes & infections.

Antibodies Against Henipa-Like Viruses in Brazilian Bats.

P. Rota, A. Tamin, C. Spiropoulou, 2017, Vector borne and zoonotic diseases.

Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus

C. Spiropoulou, S. Pegan, É. Bergeron, 2024, NPJ vaccines.

Enhanced broad spectrum in vitro antiviral efficacy of 3-F-4-MeO-Bn, 3-CN, and 4-CN derivatives of lipid remdesivir nucleoside monophosphate prodrugs

C. Spiropoulou, Xing-quan Zhang, K. Hostetler, 2023, Antiviral research.